CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Theragenics Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Theragenics Corporation
5203 Bristol Industrial Way
Phone: (770) 271-0233p:770 271-0233 BUFORD, GA  30518  United States Ticker: TGXTGX

This company ceased filing statements with the SEC on 11/12/2013.
This company is no longer actively traded on any major stock exchange.

Business Summary
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufacture, assemble, package and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201312/31/2012YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer M C.Jacobs 62 5/1/2007 1/1/1992
Chief Financial Officer, Treasurer Francis J.Tarallo 53 8/8/2005 8/8/2005
President of NeedleTech Products JosephPlante 48 10/1/2009 10/1/2009
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Arrotek Medical Ltd. Collooney Business Park Co Sligo Collooney Ireland
Galt Medical Corp. 2220 Merritt Drive Garland TX United States

Business Names
Business Name
Arrotek Medical Ltd.
CP Medical Corporation
Galt Medical Corp.
5 additional Business Names available in full report.

General Information
Number of Employees: 534 (As of 12/31/2012)
Outstanding Shares: 31,222,728 (As of 8/6/2013)
Shareholders: 346
Stock Exchange: NYSE
Federal Tax Id: 581528626
Fax Number: (770) 831-5294


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023